254 related articles for article (PubMed ID: 10545478)
1. The MHC class II ligand lymphocyte activation gene-3 is co-distributed with CD8 and CD3-TCR molecules after their engagement by mAb or peptide-MHC class I complexes.
Hannier S; Triebel F
Int Immunol; 1999 Nov; 11(11):1745-52. PubMed ID: 10545478
[TBL] [Abstract][Full Text] [Related]
2. T Lymphocytes infiltrating various tumour types express the MHC class II ligand lymphocyte activation gene-3 (LAG-3): role of LAG-3/MHC class II interactions in cell-cell contacts.
Demeure CE; Wolfers J; Martin-Garcia N; Gaulard P; Triebel F
Eur J Cancer; 2001 Sep; 37(13):1709-18. PubMed ID: 11527700
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte-activation gene 3/major histocompatibility complex class II interaction modulates the antigenic response of CD4+ T lymphocytes.
Huard B; Tournier M; Hercend T; Triebel F; Faure F
Eur J Immunol; 1994 Dec; 24(12):3216-21. PubMed ID: 7805750
[TBL] [Abstract][Full Text] [Related]
4. LAP, a lymphocyte activation gene-3 (LAG-3)-associated protein that binds to a repeated EP motif in the intracellular region of LAG-3, may participate in the down-regulation of the CD3/TCR activation pathway.
Iouzalen N; Andreae S; Hannier S; Triebel F
Eur J Immunol; 2001 Oct; 31(10):2885-91. PubMed ID: 11592063
[TBL] [Abstract][Full Text] [Related]
5. CD4-Ia interactions can occur in the absence of T-cell receptor/antigen-Ia recognition.
Andris F; Leo O; Van Mechelen M; Urbain J; Slaoui M
Immunology; 1989 Sep; 68(1):1-6. PubMed ID: 2530152
[TBL] [Abstract][Full Text] [Related]
6. Patterns of costimulation of T cell clones by cross-linking CD3, CD4/CD8, and class I MHC molecules.
Wacholtz MC; Patel SS; Lipsky PE
J Immunol; 1989 Jun; 142(12):4201-12. PubMed ID: 2470819
[TBL] [Abstract][Full Text] [Related]
7. In vivo treatment of class II MHC-deficient mice with anti-TCR antibody restores the generation of circulating CD4 T cells and optimal architecture of thymic medulla.
Nasreen M; Ueno T; Saito F; Takahama Y
J Immunol; 2003 Oct; 171(7):3394-400. PubMed ID: 14500633
[TBL] [Abstract][Full Text] [Related]
8. Interactions between CD8alphabeta and the TCRalphabeta/CD3-receptor complex.
Rubin B; Riond J; Leghait J; Gairin JE
Scand J Immunol; 2006 Sep; 64(3):260-70. PubMed ID: 16918695
[TBL] [Abstract][Full Text] [Related]
9. The roles of CD4 and CD8 in T cell activation.
Miceli MC; Parnes JR
Semin Immunol; 1991 May; 3(3):133-41. PubMed ID: 1909592
[TBL] [Abstract][Full Text] [Related]
10. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
Lustgarten J; Waks T; Eshhar Z
Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
[TBL] [Abstract][Full Text] [Related]
11. Impact of antigen presentation on TCR modulation and cytokine release: implications for detection and sorting of antigen-specific CD8+ T cells using HLA-A2 wild-type or HLA-A2 mutant tetrameric complexes.
Jäger E; Salter R; Castelli C; Höhn H; Freitag K; Karbach J; Neukirch C; Necker A; Knuth A; Maeurer MJ
J Immunol; 2002 Mar; 168(6):2766-72. PubMed ID: 11884444
[TBL] [Abstract][Full Text] [Related]
12. CD8 T cells, like CD4 T cells, are triggered by multivalent engagement of TCRs by MHC-peptide ligands but not by monovalent engagement.
Stone JD; Stern LJ
J Immunol; 2006 Feb; 176(3):1498-505. PubMed ID: 16424178
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the major histocompatibility complex class II binding site on LAG-3 protein.
Huard B; Mastrangeli R; Prigent P; Bruniquel D; Donini S; El-Tayar N; Maigret B; Dréano M; Triebel F
Proc Natl Acad Sci U S A; 1997 May; 94(11):5744-9. PubMed ID: 9159144
[TBL] [Abstract][Full Text] [Related]
14. Peptide-MHC Binding Reveals Conserved Allosteric Sites in MHC Class I- and Class II-Restricted T Cell Receptors (TCRs).
He Y; Agnihotri P; Rangarajan S; Chen Y; Kerzic MC; Ma B; Nussinov R; Mariuzza RA; Orban J
J Mol Biol; 2020 Dec; 432(24):166697. PubMed ID: 33157083
[TBL] [Abstract][Full Text] [Related]
15. MHC class II signal transduction in human dendritic cells induced by a natural ligand, the LAG-3 protein (CD223).
Andreae S; Buisson S; Triebel F
Blood; 2003 Sep; 102(6):2130-7. PubMed ID: 12775570
[TBL] [Abstract][Full Text] [Related]
16. T cell major histocompatibility complex class II molecules down-regulate CD4+ T cell clone responses following LAG-3 binding.
Huard B; Prigent P; Pagès F; Bruniquel D; Triebel F
Eur J Immunol; 1996 May; 26(5):1180-6. PubMed ID: 8647185
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens.
Baixeras E; Huard B; Miossec C; Jitsukawa S; Martin M; Hercend T; Auffray C; Triebel F; Piatier-Tonneau D
J Exp Med; 1992 Aug; 176(2):327-37. PubMed ID: 1380059
[TBL] [Abstract][Full Text] [Related]
18. CD4/major histocompatibility complex class II interaction analyzed with CD4- and lymphocyte activation gene-3 (LAG-3)-Ig fusion proteins.
Huard B; Prigent P; Tournier M; Bruniquel D; Triebel F
Eur J Immunol; 1995 Sep; 25(9):2718-21. PubMed ID: 7589152
[TBL] [Abstract][Full Text] [Related]
19. Engagement of class I major histocompatibility complex molecules by cell surface CD8 delivers an activation signal.
Geppert TD; Nguyen H; Lipsky PE
Eur J Immunol; 1992 Jun; 22(6):1379-83. PubMed ID: 1350981
[TBL] [Abstract][Full Text] [Related]
20. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
